A multipotent cell type from term human placenta

We identify a population of multipotent CDX2 cells from term human placentas with clonal expansion, migratory capacity, and immune-privileged transcriptional profiles. Isolated from 180 healthy pregnancies, these cells differentiate into cardiomyocyte and vascular lineages in vitro and in vivo . Single-cell RNA sequencing uncovers distinct cardiogenic and vasculogenic subpopulations, along with immune-modulatory and chemotactic programs, providing a blueprint for precision-guided cardiovascular cell therapy. In a NOD/SCID myocardial infarction model, CDX2 cells restore cardiac function, and clonal propagation preserves their cardiovascular differentiation potential. These findings position placental CDX2 cells as an ethically accessible, regenerative platform for targeted treatment of cardiovascular disease.